In this issue:
Fractionated dosing of CAR T-cell therapy ARI0002H promising
BCMA-targeted CAR T-cell therapy augmented by γ-secretase inhibition
Durable survival in younger myeloma patients after upfront ASCT
Isatuximab-containing quadruplet elicits deep responses
Symptom-specific screening may speed up myeloma diagnosis
RedirecTT-1: High response to dual bispecific regimen for RRMM
High infection rates associated with bispecific antibodies
PBAC recommendations
FDA grants orphan drug designation to inobrodib
PVP/PVP surgery not suitable prior to anti-myeloma therapy
T-Charge platform enables rapid production of CAR-T cells
LINKER-MM1: linvoseltamab bispecific for RR disease
COVID-19 resources
Conferences & Workshops
Please login below to download this issue (PDF)